MedTrace Logo

Effects of Probiotic Against Respiratory & Gastrointestinal Illnesses in Children

NCT05734417 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 120

Last updated 2023-10-04

No results posted yet for this study

Summary

This project aims to study the benefits of probiotics namely Bifidobacterium lactis subsp. infantis B8762 in treatment of respiratory and gastrointestinal illnesses in children, which are found common among pre-school children in Malaysia aged below 7-years old.

Conditions

  • Respiratory Tract Infections

Interventions

DIETARY_SUPPLEMENT

Probiotic

Oral administration of Bifidobacterium lactis subsp. infantis B8762 at 0.5x10 log colony forming unit (CFU)/day for 4-weeks

DIETARY_SUPPLEMENT

Placebo

Intervention consists of daily administration of 2g/sachet of excipient administered daily for 4-weeks

Sponsors & Collaborators

  • International Islamic University Malaysia

    collaborator OTHER

  • Beijing Scitop Bio-Tech Co., Ltd.

    collaborator UNKNOWN

  • Min-Tze LIONG

    lead OTHER

Principal Investigators

  • Taufiq Hidayat Hasan, MBBS · International Islamic University Malaysia

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
PARALLEL

Eligibility

Min Age
1 Month
Max Age
84 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-05-01
Primary Completion
2025-03-01
Completion
2025-03-01

Countries

  • Malaysia

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05734417 on ClinicalTrials.gov